Summary
In a significant market movement during February 2018, Ultromics was the subject of a vc funding. The transaction achieved a gross valuation of £10,000,000. Leading the round was Oxford Sciences Innovation, Tanarra, Dieter Spälti., Andre Crawford-Brunt, GT Healthcare, Neptune, Fushia, RT Ventures.
This transaction was brokered by an undisclosed advisor. The deal reflects ongoing market confidence within its sector.
Lead Investor / Acquirer
Oxford Sciences Innovation
Lead Investor / Acquirer
Tanarra
Lead Investor / Acquirer
Dieter Spälti.
Lead Investor / Acquirer
Andre Crawford-Brunt
Lead Investor / Acquirer
GT Healthcare
Lead Investor / Acquirer
Neptune
Lead Investor / Acquirer
Fushia
Lead Investor / Acquirer
RT Ventures
Advising Broker
Undisclosed Firm
Related Deals in Healthcare & Biotech
Series A prioritisedOriginal Source
This funding round is sourced from the Tech.eu Funding Explorer. View the full record, investors, and citations there.
View on Tech.eu Funding ExplorerFunding data via Tech.eu Funding Explorer, licensed under CC BY 4.0. See our methodology.
AI Insight Lenses
ProAI-generated analysis from four professional perspectives. Powered by PE Deals.
Sign in to unlock AI Lenses
Sign in